SPERO THERAPEUTICS, INC. (SPRO)

1.20 -0.83% (-0.01)

Over 1M: +2.6%

2026-08-28
Style
Area Line Line with markers Steps Candlesno open/high/low yet Hollow candlesno open/high/low yet Barsno open/high/low yet

Candles need the day’s open, high and low. Those are being collected now — a company shows them once its history has been refreshed.

1.15 1.2 1.25
31 Jul 5 Aug 10 Aug 13 Aug 18 Aug 21 Aug 26 Aug

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '21 — Revenue: 3.1M Q3 '21 — Operating Cash Flow: -5M Q3 '21 — Free Cash Flow: -5M Q3 '21 — Net Income: -22.5M Q4 '21 — Revenue: 2.7M Q4 '21 — Operating Cash Flow: -27.3M Q4 '21 — Net Income: -29.3M Q1 '22 — Revenue: 2.1M Q1 '22 — Operating Cash Flow: -28.2M Q1 '22 — Net Income: -32.8M Q2 '22 — Revenue: 2M Q2 '22 — Operating Cash Flow: -23M Q2 '22 — Net Income: -28.7M Q3 '22 — Revenue: 2M Q3 '22 — Operating Cash Flow: -957K Q3 '22 — Net Income: -11.7M Q4 '22 — Revenue: 47.4M Q4 '22 — Operating Cash Flow: 44.5M Q4 '22 — Net Income: 26.8M Q1 '23 — Revenue: 2.1M Q1 '23 — Operating Cash Flow: -12.9M Q1 '23 — Net Income: -13.3M Q2 '23 — Revenue: 2.7M Q2 '23 — Operating Cash Flow: -18.6M Q2 '23 — Net Income: -11.9M Q3 '23 — Revenue: 25.5M Q3 '23 — Operating Cash Flow: 15.9M Q3 '23 — Net Income: -3.2M Q4 '23 — Revenue: 73.5M Q4 '23 — Operating Cash Flow: -17.5M Q1 '24 — Revenue: 9.3M Q1 '24 — Operating Cash Flow: 5.9M Q1 '24 — Net Income: -12.7M Q2 '24 — Revenue: 10.2M Q2 '24 — Operating Cash Flow: -18.7M Q2 '24 — Net Income: -17.9M Q3 '24 — Revenue: 13.5M Q3 '24 — Operating Cash Flow: 12.8M Q3 '24 — Net Income: -17.1M Q4 '24 — Revenue: 15M Q4 '24 — Operating Cash Flow: -23.4M Q4 '24 — Net Income: -20.9M Q1 '25 — Revenue: 5.9M Q1 '25 — Operating Cash Flow: -4M Q1 '25 — Net Income: -13.9M Q2 '25 — Revenue: 14.2M Q2 '25 — Operating Cash Flow: -17.7M Q2 '25 — Net Income: -1.7M Q3 '25 — Revenue: 5.4M Q3 '25 — Operating Cash Flow: 17.4M Q3 '25 — Net Income: -7.4M Q4 '25 — Revenue: 41.3M Q4 '25 — Operating Cash Flow: -8.4M Q1 '26 — Revenue: 258K Q1 '26 — Operating Cash Flow: 15.9M Q1 '26 — Net Income: -7.2M Q2 '26 — Revenue: 0 Q2 '26 — Operating Cash Flow: -5.4M Q2 '26 — Net Income: -9.6M -25M 0 25M 50M 75M
Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

6.8
ROIC —
OE margin 33.2%
Oper. margin 12.8%
Accruals -20.9%
FCF margin 41.7%
OCF / EBIT 3.2×
OCF margin 41.7%
ROA 16.2%
ROCE 13.6%
ROE 19.4%
Capex / sales —
Gross margin —

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

1.0
RPO / sales —
RPO growth —
Segment HHI —

2 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

9.7
Interest cover —
ND/EBITDA —
Debt / Eq 0.0×
Debt payback 0.0 yr
Payout 0.0%
Quick ratio 6.1×
F-score 5.1 pts
Cash / Debt —
Cash runway —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

6.2
Sales CAGR 4Y +38.3%
Sales/sh Y/Y -11.5%
Sales Q/Q -100.0%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.